Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

942.55

3.35 (0.36%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences informs about transcript of AGM

>>

Zydus Lifesciences rises on getting EIR for oncology injectable manufacturing facility in Ahmedabad

>>

Zydus Lifesciences gets EIR for oncology injectable manufacturing facility in Ahmedabad

>>

Zydus Lifesciences’ arm launches first veterinary approved generic of Furosemide Tablets

>>

Zydus Lifesciences moves up as its arm launches generic of phenylpropanolamine hydrochloride tablets

>>

Zydus Lifesciences’ arm launches generic of phenylpropanolamine hydrochloride tablets

>>

USFDA conducts inspection at Zydus group’s formulation plant in Ahmedabad

>>

USFDA concludes inspection at Zydus Lifesciences’ formulation manufacturing plant at Baddi

>>

Zydus Lifesciences reports 3% rise in Q1 consolidated net profit

<< < 9 10 11 ...168 > >>